Please ensure Javascript is enabled for purposes of website accessibility
Clinical Study Validates TWO2 Therapy Effectiveness

Clinical Study Validates TWO2 Therapy Effectiveness

Galway, Ireland, May 26- AOTI announced today that a new clinical study published in the May issue of European Journal of Vascular and Endovascular Surgery demonstrates superior wound closure rates for patients suffering from refractory venous ulcers treated with its...

AOTI adds Global Medical Director

AOTI adds Global Medical Director

Galway, Ireland, May 5- AOTI, INC., announced today that Dr. Christian Frye has joined the company as its Global Medical Director and Chief Science Officer. Christian graduated from the University of Cologne, Germany in 1994 with his Medical Degree and has more than...

AOTI releases enhanced Sacral Therapy Unit

AOTI releases enhanced Sacral Therapy Unit

Galway, Ireland, April 15- AOTI announced today the release of its new enhanced multi-size Single Patient Use Sacral Units. “AOTI continues to listen to our customers and make enhancements to our products”, stated Mike Griffiths President and CEO, “our new multi-size...

AOTI appoints Vice President of Operations and Manufacturing

AOTI appoints Vice President of Operations and Manufacturing

Galway, Ireland, April 1- AOTI, INC., announced today that Gerry Coughlan has joined the company as Vice President of Operations and Manufacturing at the company’s Galway, Ireland facility. Gerry graduated has spent nearly 20 years in the medical device business in...

AOTI adds Vice President of Service and Technical Education

AOTI adds Vice President of Service and Technical Education

Galway, Ireland Feb 1- AOTI Ltd., announced today that Liam Farrell has joined the company as Vice President of Service and Technical Education. Liam graduated from the British Aerospace technical education program in the United Kingdom where he achieved an HNC in...